Kathryn M. McNeil
2013
In 2013, Kathryn M. McNeil earned a total compensation of $163.3K as Vice President of Investor Relations at Cellectar Biosciences.
Compensation breakdown
| Option Awards | $132,360 |
|---|---|
| Salary | $30,978 |
| Total | $163,338 |
McNeil received $132.4K in option awards, accounting for 81% of the total pay in 2013.
McNeil also received $31K in salary.
Rankings
In 2013, Kathryn M. McNeil's compensation ranked 11,828th out of 12,286 executives tracked by ExecPay. In other words, McNeil earned more than 3.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,828 out of 12,286 | 4th |
Division Manufacturing | 4,429 out of 4,612 | 4th |
Major group Chemicals And Allied Products | 1,402 out of 1,462 | 4th |
Industry group Drugs | 1,113 out of 1,156 | 4th |
Industry Pharmaceutical Preparations | 859 out of 890 | 4th |
Source: SEC filing on April 22, 2015.
McNeil's colleagues
We found two more compensation records of executives who worked with Kathryn M. McNeil at Cellectar Biosciences in 2013.